Top 2024 Health Diagnostics Mid Stage Investors in United States

Last Updated: August 2024

A curated list of 485 Angel Investors and VC funds that invests in Health Diagnostics startups located in United States. Investors are ranked based on the number of investments they made worldwide.

Browse all

Saved

Industry

Location

Investment Stage

Mid Stage

Include Only Business Angels?

No

Only include Company Founders?

No

485 Investors Matched (485 LinkedIn, 341 Emails, 144 Twitter)

Will Griffith

Founding Partner at ICONIQ Growth

early stage: 15 / mid stage: 52 / late stage : 41

Alexander Clarence McIntosh

Investor, Interim Assistant Customer Service Manager, Inbound Operations Expert

early stage: 21 / mid stage: 28 / late stage : 23

Alexander Tran

Partner at Plug and Play Ventures

early stage: 29 / mid stage: 26 / late stage : 8

Scott Dresden, MD, FACOG

Dresden Capital, LtD

early stage: 22 / mid stage: 13 / late stage : 5

Nicolas E.

General Partner at Partech Partners

early stage: 35 / mid stage: 18 / late stage : 4

Rany Raviv

Co Founder @ The R-Group, LLC

early stage: 35 / mid stage: 14 / late stage : 12

Helen Liang, PhD

Founder & Managing Partner of FoundersX Ventures. Featured on WSJ and Business Insider as a Pioneering Tech VC. Board Director. Invited Speaker at TechCrunch. Support AGI House Hackathons.

early stage: 45 / mid stage: 11 / late stage : 4

Michael Melikian

Co-Founder / GP & Managing Partner at 305 Ventures

early stage: 38 / mid stage: 7 / late stage : 6

Oded Hermoni - Managing Partner - J-Ventures VC Group, Silicon Valley ( J-Ventures, J-Impact, J-Angels). Former partner @Rhodium &Coin Ventures and head of the Israeli VC & tech associations( Now IATI). Advisor&Mentor for entrepreneurs

Managing Partner - J-Ventures VC Group, Silicon Valley ( J-Ventures, J-Impact, J-Angels). Former partner @Rhodium &Coin Ventures and head of the Israeli VC & tech associations( Now IATI). Advisor&Mentor for entrepreneurs

early stage: 26 / mid stage: 12 / late stage : 9

Peter Bordes

CEO Collective Audience NASDAQ: CAUD, Founder, Board Member, Investor, managing partner Trajectory Ventures & Trajectory Capital

early stage: 24 / mid stage: 17 / late stage : 11